🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an import...
Status
Not Yet Recruiting
Location
Nanfang Hospital, Southern Medical University
Start Date
2026-05-01
Trial ID
NCT07539779
Treatments Being Tested
The main aim of this study is to learn how safe elritercept is and how well...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2020-08-19
Trial ID
NCT04419649
Treatments Being Tested
Myelodysplastic syndromes, primarily affecting older adults, are a heteroge...
Status
Recruiting
Location
A.O. SS. Antonio e Biagio e Cesare Arrigo Ospedale Civile
Start Date
2022-11-03
Trial ID
NCT05924100
Treatments Being Tested
This is a single arm open-label Phase II trial of luspatercept and darbepoe...
Status
Recruiting
Location
Yale University
Start Date
2025-12-16
Trial ID
NCT07096297
Treatments Being Tested
This study aims to explore the feasibility, safety, and preliminary efficac...
Status
Recruiting
Location
Department of Hematology, Guangdong Second Provincial General Hospital
Start Date
2026-06-01
Trial ID
NCT07663864
Treatments Being Tested
In a randomized controlled phase II/III clinical trial, 58% of patients wit...
Status
Unknown
Location
Peking union medical college hospital
Start Date
2023-08
Trial ID
NCT06006949
Treatments Being Tested
To assesse the efficacy and safety of luspatercept versus placebo in China ...
Status
Unknown
Location
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Start Date
2024-01-01
Trial ID
NCT06164821
Treatments Being Tested
This is a prospective multicenter phase II basket trial evaluating Luspater...
Status
Not Yet Recruiting
Location
GCS Groupement des Hôpitaux de l'Institut Catholique de Lille
Start Date
2026-01-15
Trial ID
NCT07331818
Treatments Being Tested
This study is an open-label extension study for participants previously enr...
Status
Completed
Location
Acceleron Investigative Site
Start Date
2014-10-09
Trial ID
NCT02268383
Treatments Being Tested
Study of the combination of luspatercept in low-risk myelodysplastic syndro...
Status
Recruiting
Location
CHU Amiens-Picardie
Start Date
2022-05-18
Trial ID
NCT05181735
Treatments Being Tested